• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Imaging and Intervention

Ultrasound enhances gastrointestinal absorption of drugs at low frequencies

byDylan Wolman
November 18, 2015
in Imaging and Intervention
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1, Ultrasound can enhance the gastrointestinal delivery of drugs in porcine and rodent models through the cavitation of rectal tissue at low frequencies, increasing the permeability of the rectal and colonic tissues to multiple drugs, including macromolecules, without thermal or structural damage.

Evidence Rating: 2 (good)

Study Rundown:  Pathologies that affect the gastrointestinal (GI) mucosa often limit the efficacy of drugs delivered through the GI tract due to mucosal injury or rapid colonic transit, as in diarrheal states. In particular, macromolecular drugs such as monoclonal antibodies, peptides and nucleic acids are preferentially limited due to their bulky size. In this proof of concept study, low frequency ultrasound was used to increase the permeability of rectal tissue to enhance the delivery of drugs. Low frequency ultrasound causes a transient increase in permeability by using the sound pressure wave to physically propel therapeutic substances through tissue by a process known as transient cavitation. Various drugs, including glucose, insulin, hydrocortisone, and mesalamine were shown to have increased delivery when combined with low frequency ultrasound in an ex vivo model. Ultrasound also helped enhance drug delivery in an in-vivo swine model, effectively increasing drug delivery of both glucose and insulin. Rectal ultrasound was also shown to enhance drug delivery in a rodent model of colitis, increasing the absorption of mesalamine enemas, decreasing treatment times, and revealing superior histological scores for disease activity. This study proposes a novel utility for ultrasound in the therapeutic delivery of drugs through mucosal surfaces, particularly in disease states which benefit particularly from GI drug delivery, such as in inflammatory bowel disease. The study was limited in that it did not test the technique in outside of an animal model. Human trials would be necessary to validate the clinical efficacy of such a procedure, and to determine how feasible the rectal application of an ultrasound probe may be in practice. Additionally, concern is raised considering that such an application may be physically harmful in a patient with friable rectal tissue, such as in ulcerative colitis. Future studies examining the safety and efficacy of such an augmented form of drug delivery in humans is warranted, but also to determine if it would be an appropriate method to increase gastric, oral or subcutaneous drug absorption.

Click to read the study in Science Translational Medicine

Relevant reading: Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers

In-Depth [animal study]: This study examined ultrasound-mediated drug delivery both in an ex-vivo model utilizing fresh gastrointestinal tissue and multiple in vivo trials in both mice and pigs. The ex-vivo component used GI tissue (colon and intestine) positioned between a donor chamber and a receiving chamber (a Franz diffusion cell) with a 20 and 40 kHz ultrasound probe, showing improved delivery of glucose (intestine: p < 0.003, colon: p < 0.002), insulin (intestine: p < 0.006, colon: p < 0.0005), hydrocortisone (intestine: p < 0.0003, colon: p < 0.0005), and mesalamine (intestine: p < 0.0006, colon: p < 0.00007). In an in-vivo porcine model, improved drug delivery was observed by a biologic feedback model, demonstrated by the delivery of insulin, a small peptide drug, the response to which was measured by the rate of fall of serum blood glucose both with and without ultrasound-mediated absorption assistance (P < 0.0004). Histological samples of the treated tissue did not show any significant epithelial or mucosal disruption, even over daily application of ultrasound over two weeks. In an in vivo rodent model of inflammatory colitis (dextran sodium sulfate-induced acute colitis), animals who were treated with 40-kHz ultrasound to aid the absorption of mesalamine enemas on a daily basis had faster resolution of colitis as compared to the same treatment every other day and to daily drug enemas without ultrasound (p < 0.00029). Tissue samples taken immediately after the application of ultrasound showed a 22-fold increase in local tissue concentration of mesalamine as compared to samples not treated with ultrasound, and NMR spectroscopy confirmed the chemical stability of the drug after ultrasound treatment.

Image: CC/Wiki/MorgueFile

RELATED REPORTS

Ultrasonographic views, landmarks, and patient-specific factors to consider in a consensus-based definition of the Focused Assessment With Sonography for Trauma in children with abdominal injury

#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: pharmacologyultrasound
Previous Post

Sofosbuvir-velpatasvir shows promise in HCV genotype 2 and 3 infection: The ASTRAL 2-3 study

Next Post

Community treatment of HIV pre-exposure prophylaxis demonstrated low acquisition rate but disparities in adherence

RelatedReports

Quick Take: Efficacy of prehospital criteria in identifying trauma patients susceptible to undertriage
Emergency

Ultrasonographic views, landmarks, and patient-specific factors to consider in a consensus-based definition of the Focused Assessment With Sonography for Trauma in children with abdominal injury

March 25, 2022
#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication
StudyGraphics

#VisualAbstract: Only one quarter of benzodiazepine prescriptions in youth are for approved indication

December 29, 2021
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Only one quarter of benzodiazepine prescriptions in youth are for approved indication

December 24, 2021
Pediatric DKA associated with recent acute care visits
Chronic Disease

Sodium-glucose cotransporter 2 inhibitors associated with reduced mortality compared with sulfonylureas in patients with type 2 diabetes

July 1, 2021
Next Post
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men

Community treatment of HIV pre-exposure prophylaxis demonstrated low acquisition rate but disparities in adherence

Non-invasive prenatal testing linked to decreased diagnostic testing

New data on prevalence and spectrum of germline mutations in pediatric cancer patients

[CORAL-1 trial] Interferon-free regimen for recurrent hepatitis C after liver transplant safe and effective

Sofosbuvir-velpatasvir may provide sustained virologic response in Hepatitis C cirrhotics: The ASTRAL-4 study

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.